May Edition
FlowerHire
Comprehensive recruitment and advisory services for cannabis companies. We are Talent in Cannabis.
Happy Friday!
This week, we're talking about the implications of rescheduling and what it means for the industry.
Enjoy the read.
Today's update: 450 words /3 minute read
The End of the Beginning
by Mike Siebold
What now?! That HOT swirl of chatter from the capital to the coffee break room, from pundits to wonks, in and out of cannabis, would be exciting if the obvious wasn’t so confusing. With POTUS's brief yet exacting video, the hourglass has officially swung upside down, and the countdown has begun. Our illegitimate yet mainstream industry has new contours to it…eventually. The out-group is the in-group, yet the old group is not the same suddenly. In conversation and, god help us, online, the reactions of the cannabis faithful have crested, from jubilant to dejected.
To boot, you also had the complete closure of Medmen, once touted as our Apple and now firmly entrenched in the annals of cannabis businesses as a cautionary tale, mere moments before the rescheduling news. Fate is not without a sense of irony. All the same, please stretch and hydrate; what’s to come is business as usual, plus plus.
Why it matters in Weed: It’s one of the largest changes made in drug policy in America in a century. Given the lengths to which opposition groups and public service announcements denounced cannabis, it’s also a great feeling to spike the ball and point to the fact that cannabis is and will continue to be medicine. Activists and capitalists are feeling saucy, even if they’ll never be able to reconcile or trust one another fully.
A new day, same weather. The fundamentals, outside 280-E, have not changed. Criminality and criminalization have not changed. Banking is absent, though the financing realm is going to morph significantly in the near term. The pharmacological implications should be celebrated from the rooftops, considering this is still the same nation that is still grappling with the opioid health blight that has caused untold amounts of pain and anguish.
Yet, with FDA oversight kinda-sorta entering the chat, it’s potentially no longer medicine on our terms, but squarely in the remit of the government and, by virtue of that, special interest….supposedly. Theories abound about our collective future, each provided in the echo chamber that is social media and forums. Honestly, maybe we should demand answers with our new political clout rather than experiencing the consequences. Maybe that’s the larger topic we should focus on: crafting political and public policy. Given the potential for financial and societal benefit, we should grab our future firmly with both hands.
Connect with us
FlowerHire Advisors guides cannabis companies to strategically improve their human capital processes for compliance, performance management, retention, compensation design, and other specific needs.
Is your management team in need of strategic support?
Email us at HR@flowerhire.com